Skip to main content
Alpa Laboratories Limited logo

Alpa Laboratories Limited — Investor Relations & Filings

Ticker · ALPA ISIN · INE385I01010 LEI · 335800O2RIWENG8KPR59 BSE.NS Manufacturing
Filings indexed 321 across all filing types
Latest filing 2024-12-30 Regulatory Filings
Country IN India
Listing BSE.NS ALPA

About Alpa Laboratories Limited

https://alpalabs.in/

Alpa Laboratories Limited specializes in the development and manufacture of a broad range of pharmaceutical formulations for human and veterinary applications. The company's core capabilities include the production of small volume parenterals, such as liquid and dry powder injections, alongside solid orals like tablets and capsules. Its portfolio further extends to topical preparations including ointments, creams, gels, and ophthalmic/otic drops. Utilizing WHO-GMP certified manufacturing units, the organization provides extensive contract manufacturing and research services to prominent global healthcare brands. The company serves diverse therapeutic segments, including anti-infectives, analgesics, and nutritional supplements, maintaining a robust presence in both domestic and international markets through a commitment to stringent quality standards and technical excellence.

Recent filings

Filing Released Lang Actions
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (69 characters) and contains no substantive content, only placeholders and an omitted picture. There is no financial data, report content, or any announcement text. Given the lack of any meaningful information, this document cannot be classified as a report or announcement type. It fits best as a Regulatory Filing (RNS) fallback category due to absence of specific content.
2024-12-30 English
Resignation
Regulatory Filings
2024-11-14 English
Related Party Transactions
Regulatory Filings Classification · 85% confidence The document text is very short (498 characters) and appears to be a tabular excerpt related to transactions involving Key Managerial Personnel (KMP) and their relatives, including remuneration details. There is no indication of a full report, financial statements, or comprehensive analysis. The content resembles a snippet from a remuneration or related party transaction disclosure. Given the brevity and nature of the content, it is not a full Remuneration Information report (DEF 14A) but rather a partial disclosure or regulatory filing. Since it does not fit neatly into other categories and is a brief disclosure, the best classification is Regulatory Filings (RNS).
2024-11-14 English
Outcome of Board Meeting
Regulatory Filings
2024-11-14 English
Financial Result Updates
Regulatory Filings
2024-11-14 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2024-11-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.